General and Administrative Expense of Galmed Pharmaceuticals Ltd. from 31 Dec 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Galmed Pharmaceuticals Ltd. quarterly and annual General and Administrative Expense in USD history and change rate from 31 Dec 2012 to 30 Sep 2025.
  • Galmed Pharmaceuticals Ltd. General and Administrative Expense for the quarter ending 30 Sep 2025 was $1,009,000, a 21% decline year-over-year.
  • Galmed Pharmaceuticals Ltd. annual General and Administrative Expense for 2024 was $3,299,000, a 16% decline from 2023.
  • Galmed Pharmaceuticals Ltd. annual General and Administrative Expense for 2023 was $3,923,000, a 16% decline from 2022.
  • Galmed Pharmaceuticals Ltd. annual General and Administrative Expense for 2022 was $4,656,000, a 18% decline from 2021.
Source SEC data
View on sec.gov
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Change (%)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Change (%)

Galmed Pharmaceuticals Ltd. Quarterly General and Administrative Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,009,000 -$264,000 -21% 01 Jul 2025 30 Sep 2025 6-K 26 Nov 2025 2025 Q3
Q2 2025 $1,051,000 +$363,000 +53% 01 Apr 2025 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q3 2024 $1,273,000 01 Jul 2024 30 Sep 2024 6-K 26 Nov 2025 2025 Q3
Q2 2024 $688,000 -$374,000 -35% 01 Apr 2024 30 Jun 2024 6-K 28 Aug 2025 2025 Q2
Q2 2023 $1,062,000 -$88,000 -7.7% 01 Apr 2023 30 Jun 2023 6-K 28 Aug 2024 2024 Q2
Q2 2022 $1,150,000 -$226,000 -16% 01 Apr 2022 30 Jun 2022 6-K 09 Aug 2023 2023 Q2
Q2 2021 $1,376,000 +$531,000 +63% 01 Apr 2021 30 Jun 2021 6-K 04 Aug 2022 2022 Q2
Q2 2020 $845,000 -$362,000 -30% 01 Apr 2020 30 Jun 2020 6-K 05 Aug 2021 2021 Q2
Q2 2019 $1,207,000 +$102,000 +9.2% 01 Apr 2019 30 Jun 2019 6-K 06 Aug 2020 2020 Q2
Q2 2018 $1,105,000 +$481,000 +77% 01 Apr 2018 30 Jun 2018 6-K 05 Aug 2019 2019 Q2
Q2 2017 $624,000 -$237,000 -28% 01 Apr 2017 30 Jun 2017 6-K 02 Aug 2018 2018 Q2
Q2 2016 $861,000 -$106,000 -11% 01 Apr 2016 30 Jun 2016 6-K 31 Jul 2017 2017 Q2
Q2 2015 $967,000 01 Apr 2015 30 Jun 2015 6-K 23 Jun 2017 2016 Q2

Galmed Pharmaceuticals Ltd. Annual General and Administrative Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,299,000 -$624,000 -16% 01 Jan 2024 31 Dec 2024 20-F 02 Apr 2025 2024 FY
2023 $3,923,000 -$733,000 -16% 01 Jan 2023 31 Dec 2023 20-F 02 Apr 2025 2024 FY
2022 $4,656,000 -$1,005,000 -18% 01 Jan 2022 31 Dec 2022 20-F 02 Apr 2025 2024 FY
2021 $5,661,000 +$1,533,000 +37% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 $4,128,000 -$68,000 -1.6% 01 Jan 2020 31 Dec 2020 20-F 29 Mar 2023 2022 FY
2019 $4,196,000 -$244,000 -5.5% 01 Jan 2019 31 Dec 2019 20-F 02 May 2022 2021 FY
2018 $4,440,000 +$641,000 +17% 01 Jan 2018 31 Dec 2018 20-F 18 Mar 2021 2020 FY
2017 $3,799,000 +$721,000 +23% 01 Jan 2017 31 Dec 2017 20-F 12 Mar 2020 2019 FY
2016 $3,078,000 -$168,000 -5.2% 01 Jan 2016 31 Dec 2016 20-F 13 Mar 2019 2018 FY
2015 $3,246,000 +$768,000 +31% 01 Jan 2015 31 Dec 2015 20-F 13 Mar 2018 2017 FY
2014 $2,478,000 -$4,877,000 -66% 01 Jan 2014 31 Dec 2014 20-F 23 Mar 2017 2016 FY
2013 $7,355,000 +$6,661,000 +960% 01 Jan 2013 31 Dec 2013 20-F 22 Mar 2016 2015 FY
2012 $694,000 01 Jan 2012 31 Dec 2012 20-F 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.